Press Release
AimedBio Secures Equity Investment from Samsung Life Science Fund
2023.09.13
- - AimedBio has received an equity investment from the Samsung Life Science Fund, a fund jointly established by Samsung C&T, Samsung Biologics, and Samsung Bioepis.
- This marks the first domestic investment made by the Samsung Group through the fund. - - The partnership will also include joint research on ADC toolbox development and the execution of a KDDF-funded contract development project for AMB001, which was selected earlier this year.